New York S00493 mandates health practitioners to discuss risks of certain pain medications with patients before prescribing them, especially focusing.
New York S00493 amends the public health law to require health practitioners to discuss the risks associated with certain pain medications with patients before prescribing them. This includes the first opioid analgesic prescription of a calendar year, where the prescribing physician must counsel the patient on the risks of overdose and inform them of the availability of opioid antagonists, such as naloxone.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.